ELIZABETH CALICUTT: Open Payments
NPI 1518621473 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 71 payments from 24 companies in 2025. Trend: 2023 $880 · 2024 $972 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $184 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Novo Nordisk Inc | 9 | $140 |
| Sumitomo Pharma America, Inc. | 4 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $93 |
| Astellas Pharma US Inc | 4 | $88 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
Products named: LEQVIO, UBRELVY, GEMTESA, Kerendia, Veozah, PREVNAR 20, TRELEGY ELLIPTA, Wegovy.
Industry payments across SC — which companies pay providers there.
